Sign in

CIK 0001919246

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
863335449
Phone
+1 919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$44,939
in 3 filings, $45K under 10b5-1 plans

Net −$44,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-11 Davis Todd C Director Purchase +35,445 $27.80 $986K 75,331
2026-06-11 Davis Todd C Director Purchase +503 $28.73 $14K 75,834
2025-07-02 Davis Todd C Director Grant or award +19,108 39,886
2025-07-02 Davis Todd C Director Grant or award · Restricted Stock Units +19,108 36,969
2025-07-02 Davis Todd C Director Grant or award · Stock Option +58,230 58,230
2025-07-01 Davis Todd C Director Conversion +1,500,000 $10.00 $15.0M 1,500,000
2025-07-01 Davis Todd C Director Conversion · Series A Convertible Preferred Stock −15,000 3,000
2025-07-01 Davis Todd C Director Other acquisition · Series A Convertible Preferred Stock +31,278.68 3,127,868
2024-11-13 Davis Todd C Director Grant or award +4,961 20,778
2024-11-13 Davis Todd C Director Grant or award · Restricted Stock Units +49,605 263,306
2024-06-14 Davis Todd C Director Grant or award +12,900 15,817
2024-06-14 Davis Todd C Director Grant or award · Restricted Stock Units +128,977 213,701
2024-02-21 Davis Todd C Director Exercise or conversion +29,167 $4.80 $140K 29,167
2024-02-21 Davis Todd C Director Conversion · Secured Convertible Promissory Note −0 0

Page 1 of 1 · 14 trades